Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6017

Why are BridgeBio and Alnylam both seeing strong growth for their heart drugs?

$
0
0
The much-ballyhooed competition between BridgeBio and Alnylam has been less of a tug-of-war and more of a rising-tide-lifts-all-boats scenario. That’s because both companies are hitting the milestones they each laid out for the respective launches ...

Viewing all articles
Browse latest Browse all 6017

Trending Articles